Hollsteen
← Cadence

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 2016: $1.2B · 10-Q 0000813672-16-000045 filed Apr 25, 2016Equity incl. NCI · Q2 2016: $1.1B · 10-Q 0000813672-16-000050 filed Jul 25, 2016Equity incl. NCI · Q3 2016: $927M · 10-Q 0000813672-16-000056 filed Oct 24, 2016Equity incl. NCI · Q4 2016: $742M · 10-K 0000813672-17-000006 filed Feb 10, 2017Equity incl. NCI · Q1 2017: $841M · 10-Q 0000813672-17-000011 filed Apr 25, 2017Equity incl. NCI · Q2 2017: $952M · 10-Q 0000813672-17-000017 filed Jul 24, 2017Equity incl. NCI · Q3 2017: $1.0B · 10-Q 0000813672-17-000023 filed Oct 26, 2017Equity incl. NCI · Q4 2017: $989M · 10-K 0000813672-18-000008 filed Feb 20, 2018Equity incl. NCI · Q1 2018: $1.1B · 10-Q 0000813672-18-000014 filed Apr 25, 2018Equity incl. NCI · Q2 2018: $1.2B · 10-Q 0000813672-18-000020 filed Jul 23, 2018Equity incl. NCI · Q3 2018: $1.3B · 10-Q 0000813672-18-000025 filed Oct 22, 2018Equity incl. NCI · Q4 2018: $1.3B · 10-K 0000813672-19-000008 filed Feb 27, 2019Equity incl. NCI · Q1 2019: $1.4B · 10-Q 0000813672-19-000014 filed Apr 22, 2019Equity incl. NCI · Q2 2019: $1.4B · 10-Q 0000813672-19-000022 filed Jul 22, 2019Equity incl. NCI · Q3 2019: $1.5B · 10-Q 0000813672-19-000027 filed Oct 21, 2019Equity incl. NCI · Q4 2019: $2.1B · 10-K 0000813672-20-000007 filed Feb 24, 2020Equity incl. NCI · Q1 2020: $2.2B · 10-Q 0000813672-20-000013 filed Apr 20, 2020Equity incl. NCI · Q2 2020: $2.3B · 10-Q 0000813672-20-000020 filed Jul 20, 2020Equity incl. NCI · Q3 2020: $2.4B · 10-Q 0000813672-20-000027 filed Oct 19, 2020Equity incl. NCI · Q4 2020: $2.5B · 10-K 0000813672-21-000009 filed Feb 22, 2021Equity incl. NCI · Q1 2021: $2.5B · 10-Q 0000813672-21-000016 filed Apr 26, 2021Equity incl. NCI · Q2 2021: $2.5B · 10-Q 0000813672-21-000028 filed Jul 26, 2021Equity incl. NCI · Q3 2021: $2.6B · 10-Q 0000813672-21-000037 filed Oct 25, 2021Equity incl. NCI · Q4 2021: $2.7B · 10-K 0000813672-22-000012 filed Feb 22, 2022Equity incl. NCI · Q1 2022: $2.8B · 10-Q 0000813672-22-000022 filed Apr 25, 2022Equity incl. NCI · Q2 2022: $2.6B · 10-Q 0000813672-22-000037 filed Jul 25, 2022Equity incl. NCI · Q3 2022: $2.7B · 10-Q 0000813672-22-000054 filed Oct 24, 2022Equity incl. NCI · Q4 2022: $2.7B · 10-K 0000813672-23-000011 filed Feb 13, 2023Equity incl. NCI · Q1 2023: $2.9B · 10-Q 0000813672-23-000025 filed Apr 24, 2023Equity incl. NCI · Q2 2023: $2.9B · 10-Q 0000813672-23-000041 filed Jul 24, 2023Equity incl. NCI · Q3 2023: $3.1B · 10-Q 0000813672-23-000068 filed Oct 23, 2023Equity incl. NCI · Q4 2023: $3.4B · 10-K 0000813672-24-000034 filed Feb 14, 2024Equity incl. NCI · Q1 2024: $3.6B · 10-Q 0000813672-24-000092 filed Apr 24, 2024Equity incl. NCI · Q2 2024: $4.3B · 10-Q 0000813672-24-000155 filed Jul 24, 2024Equity incl. NCI · Q3 2024: $4.6B · 10-Q 0000813672-24-000192 filed Oct 30, 2024Equity incl. NCI · Q4 2024: $4.7B · 10-K 0000813672-25-000024 filed Feb 21, 2025Equity incl. NCI · Q1 2025: $4.8B · 10-Q 0000813672-25-000051 filed Apr 30, 2025Equity incl. NCI · Q2 2025: $5.0B · 10-Q 0000813672-25-000113 filed Jul 30, 2025Equity incl. NCI · Q3 2025: $5.2B · 10-Q 0000813672-25-000148 filed Oct 29, 2025Equity incl. NCI · Q4 2025: $5.5B · 10-K 0000813672-26-000016 filed Feb 19, 2026Equity incl. NCI · Q1 2026: $6.6B · 10-Q 0000813672-26-000047 filed May 1, 20264,5636,5611,234Q1 2016Q1 2026Q3 2024
Q3 2024
4,563$M
All values (41)
PeriodValue ($M)Status
Q1 20266,561reported
Q4 20255,474reported
Q3 20255,199reported
Q2 20255,007reported
Q1 20254,776reported
Q4 20244,674reported
Q3 20244,563reported
Q2 20244,261reported
Q1 20243,568reported
Q4 20233,404reported
Q3 20233,114reported
Q2 20232,908reported
Q1 20232,941reported
Q4 20222,745reported
Q3 20222,708reported
Q2 20222,625reported
Q1 20222,760reported
Q4 20212,741reported
Q3 20212,631reported
Q2 20212,517reported
Q1 20212,542reported
Q4 20202,493reported
Q3 20202,396reported
Q2 20202,257reported
Q1 20202,158reported
Q4 20192,103reported
Q3 20191,480reported
Q2 20191,431reported
Q1 20191,366reported
Q4 20181,288reported
Q3 20181,257reported
Q2 20181,188reported
Q1 20181,142reported
Q4 2017989reported
Q3 20171,011reported
Q2 2017952reported
Q1 2017841reported
Q4 2016742reported
Q3 2016927reported
Q2 20161,075reported
Q1 20161,234reported

CSV with all sources · Technical ID: equity_total

More metrics for Cadence
Sources & calculation
Value
$4.6B
Period
Q3 2024, ended Sep 30, 2024 · as of Sep 30, 2024 (balance as of date, not a sum)
Source
10-Q, filed Oct 30, 2024 · 0000813672-24-000192
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$4.6BOct 30, 202410-Q 0000813672-24-000192reported · confidence 1. · current